The ALPMF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALPMF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ALPMF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View ALPMF Detailed Price Forecast - CNN Money | View ALPMF Detailed Summary - Google Finance | ||
View ALPMF Detailed Summary - Yahoo! Finance | View ALPMF Stock Research & Analysis - Zacks.com |
View ALPMF Trends & Analysis - Trade-Ideas | View ALPMF Major Holders - Barrons | ||
View ALPMF Call Transcripts - NASDAQ | View ALPMF Breaking News & Analysis - Seeking Alpha | ||
View ALPMF Annual Report - CompanySpotlight.com | View ALPMF OTC Short Report - OTCShortReport.com | ||
View ALPMF Fundamentals - TradeKing | View ALPMF SEC Filings - Bar Chart | ||
View Historical Prices for ALPMF - The WSJ | View Performance/Total Return for ALPMF - Morningstar | ||
View the Analyst Estimates for ALPMF - MarketWatch | View the Earnings History for ALPMF - CNBC | ||
View the ALPMF Earnings - StockMarketWatch | View ALPMF Buy or Sell Recommendations - MacroAxis | ||
View the ALPMF Bullish Patterns - American Bulls | View ALPMF Short Pain Metrics - ShortPainBot.com |
View ALPMF Stock Mentions - StockTwits | View ALPMF Stock Mentions - PennyStockTweets | ||
View ALPMF Stock Mentions - Twitter | View ALPMF Investment Forum News - Investor Hub | ||
View ALPMF Stock Mentions - Yahoo! Message Board | View ALPMF Stock Mentions - Seeking Alpha |
View Insider Transactions for ALPMF - SECform4.com | View Insider Transactions for ALPMF - Insider Cow | ||
View ALPMF Major Holdings Summary - CNBC | View Insider Disclosure for ALPMF - OTC Markets | ||
View Insider Transactions for ALPMF - Yahoo! Finance | View Institutional Holdings for ALPMF - NASDAQ |
View ALPMF Stock Insight & Charts - FinViz.com | View ALPMF Investment Charts - StockCharts.com | ||
View ALPMF Stock Overview & Charts - BarChart | View ALPMF User Generated Charts - Trading View |
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Posted on Tuesday April 23, 2024
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the European Commission (EC) has approved a label extension for XTANDI™ (enzalutamide) as monotherapy or in combination with androgen deprivation therapy (ADT) for the treatment of adult men with high-risk biochemical recurrent (BCR) non-metastatic hormone-sensitive prostate cancer (nmHSPC) who are unsuitable for salvage-radiotherapy.
Pharmas form joint venture to jumpstart Japanese drug research
Posted on Monday April 22, 2024
A new initiative backed by Takeda, Astellas and Sumitomo Mitsui Banking aims to combat a decade-long decline in drug R&D productivity in Japan.
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Posted on Monday April 22, 2024
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK, President and CEO; Christophe Weber, "Takeda"), Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas"), and Sumitomo Mitsui Banking Corporation (President & CEO: Akihiro Fukutome, "SMBC") today announced that the three companies signed a master agreement on April 22, 2024, to establish a joint venture company. The new company will be dedicated to the incubation*1 of early drug discovery programs, primarily origin
U.S. Stocks Erase Early Gains
Posted on Monday April 15, 2024
U.S. stocks extended recent declines as March retail sales increased more than expected, causing traders scale back bets on Fed rate cuts.